Although the metastasic breast cancer is still an incurable disease, recent advances have increased significantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference.
Breast Neoplasms/therapy , Neoplasm Recurrence, Local/therapy , Practice Guidelines as Topic/standards , Breast Neoplasms/pathology , Clinical Trials as Topic , Combined Modality Therapy , Disease Management , Female , Humans , Neoplasm Recurrence, Local/pathology , Prognosis , Societies, Medical
Although the metastasic breast cancer is still an incurable disease, recent advances have increased significantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference
No disponible
Humans , Female , Breast Neoplasms/pathology , Neoplasm Recurrence, Local/pathology , Neoplasm Metastasis/pathology , Neoplasm Recurrence, Local/therapy , Breast Neoplasms/therapy , Quality of Life/psychology , Practice Patterns, Physicians'
Patients with metastatic breast cancer have a wide number of treatment options, including medical, surgical, and supportive care measures. Treatment decisions are based in predictive and prognostic factors and the informed choice of the patients. SEOM has elaborated these guidelines with evidence-based recommendations for the diagnostic work-up, treatment (chemotherapy, endocrine therapy and targeted therapies) and supportive care for the management of these patient (AU)
Humans , Female , Breast Neoplasms/pathology , Breast Neoplasms/therapy , Algorithms , Breast Neoplasms/diagnosis , Neoplasm Metastasis , Prognosis , Societies, Medical/trends , Societies, Medical , Spain/epidemiology